Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
112.54 CHF | -1.35% |
|
-2.73% | +11.82% |
14.02. | Schweizer Marktindex bricht Rallye ab, da die Tarifgespräche belastend wirken | MT |
14.02. | Galderma erhält EU-Zulassung für die Behandlung von atopischer Dermatitis und Prurigo Nodularis | MT |
Zu einer Liste hinzufügen 0 ausgewählt | % | % 5 Tage | Veränderung - 1 Monat | Veränderung - 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 J. | Veränd. 5 J. | Veränd. 10 J. | Kap.($) | |
---|---|---|---|---|---|---|---|---|---|---|---|
-1.35% | -2.73% | +3.44% | +31.38% | +11.82% | - | - | - | - | 29.96 Mrd. | ||
+0.32% | +0.81% | +5.11% | +4.11% | +0.44% | -20.39% | -2.76% | +28.02% | +122.23% | 191 Mrd. | ||
-0.11% | +3.81% | +12.41% | +5.33% | +3.94% | +20.12% | +27.96% | -23.98% | +30.63% | 20.19 Mrd. | ||
-3.67% | +3.52% | +1.49% | -8.80% | -8.27% | -37.23% | -60.13% | -64.19% | +28.31% | 6.93 Mrd. | ||
-2.96% | -17.46% | -17.21% | -26.48% | -19.83% | -51.98% | -39.35% | -51.10% | -74.67% | 5.01 Mrd. | ||
+0.34% | -7.60% | -0.77% | +4.29% | +11.35% | -7.01% | -33.31% | -38.25% | -59.48% | 4.97 Mrd. | ||
+0.33% | +3.30% | +1.15% | -11.12% | +0.65% | -0.19% | -0.77% | +54.86% | - | 4.59 Mrd. | ||
-5.14% | -2.26% | +1.20% | +1.56% | +0.95% | -9.66% | +38.06% | +89.68% | +382.06% | 4.48 Mrd. | ||
+1.06% | +3.75% | +9.72% | +7.52% | +5.15% | -4.18% | -14.01% | +86.23% | +316.75% | 3.37 Mrd. | ||
+8.15% | +8.33% | +8.76% | -5.91% | +6.03% | -18.98% | -41.25% | -73.41% | - | 3.14 Mrd. | ||
-1.51% | +0.92% | -0.56% | +1.44% | +2.33% | -0.26% | - | - | - | 2.49 Mrd. | ||
-1.60% | -2.89% | -3.43% | -5.36% | -10.99% | -31.44% | -44.82% | -58.02% | +17.03% | 2.42 Mrd. | ||
+0.67% | +3.02% | +3.05% | -21.37% | -1.76% | -31.75% | -72.41% | - | - | 2.42 Mrd. | ||
-0.95% | -2.16% | -5.00% | -5.34% | -8.92% | +16.56% | - | - | - | 1.89 Mrd. | ||
+3.83% | +1.20% | -0.13% | +19.15% | +8.90% | -1.81% | - | - | - | 1.87 Mrd. | ||
-0.67% | -2.41% | -5.52% | +0.10% | -3.50% | +7.42% | +11.38% | -53.69% | - | 1.72 Mrd. | ||
-0.46% | -7.91% | -5.48% | -2.49% | +3.61% | -26.45% | -51.02% | -69.86% | -83.81% | 1.22 Mrd. | ||
+1.00% | -3.37% | -2.00% | +14.14% | +1.81% | +29.74% | +86.72% | +101.06% | +30.86% | 1.19 Mrd. | ||
+3.78% | +7.07% | +6.68% | +17.54% | +20.27% | - | - | - | - | 1.17 Mrd. | ||
-0.58% | +0.12% | -8.01% | -13.81% | -12.05% | -16.73% | -15.92% | -16.57% | +93.40% | 967 Mio. | ||
Durchschnitt | +0.02% | -0.58% | +0.25% | +0.29% | +0.60% | -10.23% | -14.11% | -6.37% | +73.03% | 14.55 Mrd. | |
Gewichteter Durchschnitt nach Marktkapitalisierung | -0.03% | -2.05% | +4.43% | +5.53% | +1.54% | -16.49% | -3.90% | +17.82% | +108.94% |
- Börse
- Aktien
- A407X6 Aktie
- Sektor Galderma Group AG

MarketScreener is also available in this country: United States.
Switch edition